share_log

Rigel Pharmaceuticals | 8-K: Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

SEC announcement ·  Mar 5 16:18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more